Literature DB >> 9201280

Glutathione and glutathione metabolizing enzymes in tissues and blood of breast cancer patients.

J Gromadzińska1, W Wasowicz, M Andrijewski, M Skłodowska, O Z Quispe, P Wołkanin, B Ołborski, A Płuzańska.   

Abstract

Many reports indicate that glutathione and enzymes cooperating with it are important in neoplastic processes. Glutathione (GSH) concentrations and glutathione S-transferase (GSH STr) and glutathione peroxidase (GSH-Px) activities were determined in breast cancer tissue and adjacent healthy tissues, as well as in blood of 28 patients. There were considerable differences in the investigated parameters among individual patients. Therefore we analyzed the paired samples of normal and cancerous tissues from the same individual. In 68% of the patients the activities of GSH-Px and in 85% patients those of GSH STr were found to be higher in the tumor than in the normal tissue. GSH concentration in 48% tumor samples were higher and in 44% lower than in corresponding normal tissues. Statistically significant correlation was found between GSH-Px and GSH STr in normal (r = 0.51, p < 0.005) and in cancer tissues (r = 0.64, p = 0.001). Correlation coefficient between GSH Px activity in normal and corresponding cancer tissues was r = 0.71 (p < 0.001), however this correlation in the case of GSH STr was much lower but still significant (r = 0.38, p < 0.05). No significant correlation in the determined parameters was found between erythrocytes or plasma and normal or cancer tissues.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9201280

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  6 in total

1.  Molecular characterization of tumor associated antigen in mice exposed to a hepatocarcinogen.

Authors:  Anis Alam; Laishram Indira Singha; Vinod Singh
Journal:  Mol Cell Biochem       Date:  2005-03       Impact factor: 3.396

2.  The GSTT1 polymorphism of the glutathione S-transferase system in the intratumoral microvessel density of breast cancer patients.

Authors:  Gustavo J Lourenço; André A Schenka; Cassio Cardoso-Filho; Glauce A Pinto; Maria S Costa-Gurgel; José Vassallo; Carmen Silvia Passos Lima
Journal:  Tumour Biol       Date:  2010-06-19

3.  A microfluidic technique for monitoring bloodstream analytes indicative of C-peptide resistance in type 2 diabetes.

Authors:  Teresa D'Amico Oblak; Jennifer A Meyer; Dana M Spence
Journal:  Analyst       Date:  2008-11-27       Impact factor: 4.616

4.  Estrogen-induced breast cancer: alterations in breast morphology and oxidative stress as a function of estrogen exposure.

Authors:  Sarah M Mense; Fabrizio Remotti; Ashima Bhan; Bhupendra Singh; Mahmoud El-Tamer; Tom K Hei; Hari K Bhat
Journal:  Toxicol Appl Pharmacol       Date:  2008-07-01       Impact factor: 4.219

5.  Protein modifications as potential biomarkers in breast cancer.

Authors:  Hongjun Jin; Richard C Zangar
Journal:  Biomark Insights       Date:  2009-11-30

6.  Mutant p53 protein expression and antioxidant status deficiency in breast cancer.

Authors:  Zorka Milicevic; Jelena Kasapovic; Ljubica Gavrilovic; Zorka Milovanovic; Vladan Bajic; Biljana Spremo-Potparevic
Journal:  EXCLI J       Date:  2014-06-23       Impact factor: 4.068

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.